BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24827915)

  • 21. Optimization of microdermabrasion for controlled removal of stratum corneum.
    Andrews SN; Zarnitsyn V; Bondy B; Prausnitz MR
    Int J Pharm; 2011 Apr; 407(1-2):95-104. PubMed ID: 21272628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microneedles for transdermal drug delivery: a systematic review.
    Dharadhar S; Majumdar A; Dhoble S; Patravale V
    Drug Dev Ind Pharm; 2019 Feb; 45(2):188-201. PubMed ID: 30348022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum].
    Sugino M; Todo H; Sugibayashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1453-8. PubMed ID: 19952520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current developments using emerging transdermal technologies in physical enhancement methods.
    Nanda A; Nanda S; Ghilzai NM
    Curr Drug Deliv; 2006 Jul; 3(3):233-42. PubMed ID: 16848725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles.
    Han T; Das DB
    J Pharm Sci; 2013 Oct; 102(10):3614-22. PubMed ID: 23873449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Advancements in Transdermal Biosensing and Targeted Drug Delivery.
    Pandey PC; Shukla S; Skoog SA; Boehm RD; Narayan RJ
    Sensors (Basel); 2019 Feb; 19(5):. PubMed ID: 30823435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal iontophoresis of sodium nonivamide acetate. V. Combined effect of physical enhancement methods.
    Fang JY; Hwang TL; Huang YB; Tsai YH
    Int J Pharm; 2002 Mar; 235(1-2):95-105. PubMed ID: 11879744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications.
    Akhtar N; Singh V; Yusuf M; Khan RA
    Biomed Tech (Berl); 2020 May; 65(3):243-272. PubMed ID: 31926064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques.
    Lanke SS; Strom JG; Banga AK
    Crit Rev Ther Drug Carrier Syst; 2009; 26(6):581-606. PubMed ID: 20402624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum.
    Andrews SN; Jeong E; Prausnitz MR
    Pharm Res; 2013 Apr; 30(4):1099-109. PubMed ID: 23196771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedles for transdermal drug delivery: a minireview.
    Vandervoort J; Ludwig A
    Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming skin barriers through advanced transdermal drug delivery approaches.
    Phatale V; Vaiphei KK; Jha S; Patil D; Agrawal M; Alexander A
    J Control Release; 2022 Nov; 351():361-380. PubMed ID: 36169040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound and transdermal drug delivery.
    Lavon I; Kost J
    Drug Discov Today; 2004 Aug; 9(15):670-6. PubMed ID: 15279850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How physical techniques improve the transdermal permeation of therapeutics: A review.
    Gao Y; Du L; Li Q; Li Q; Zhu L; Yang M; Wang X; Zhao B; Ma S
    Medicine (Baltimore); 2022 Jul; 101(26):e29314. PubMed ID: 35777055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy.
    Coulman S; Allender C; Birchall J
    Crit Rev Ther Drug Carrier Syst; 2006; 23(3):205-58. PubMed ID: 17206925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo.
    Curdy C; Kalia YN; Guy RH
    J Pharm Pharmacol; 2001 Jun; 53(6):769-77. PubMed ID: 11428652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.